Pfizer Inc. (NYSE: PFE), a global pharmaceutical company specializing in vaccines and medicines, announced that its bivalent RSV prefusion F (RSVpreF) vaccine, ABRYSVO, has received approval from the U.S. Food and Drug Administration (FDA). 

The vaccine aims to prevent lower respiratory tract disease caused by Respiratory Syncytial Virus (RSV) in individuals aged 60 years and older. RSV is a contagious virus that commonly leads to respiratory illness, potentially causing severe complications. 

After the announcement, $PFE showed a modest rise of $0.08 (+0.21%) in after-hours, trading at $38.10.

In other news, Victoria's Secret & Co. (NYSE: VSCO), a prominent retailer of women's lingerie, apparel, and beauty products, reported first-quarter 2023 adjusted earnings per share (EPS) of $0.28, which fell short of market consensus expectations of $0.54. 

The company's forecast for the second quarter of 2023 indicates an adjusted net income range of $0.10 to $0.40 per diluted share, deviating from the consensus estimate of $0.88 for the period. 

As a result, $VSCO experienced a significant decline of $3.22 (-15.77%) in after-hours, trading at $17.20.

nCino, Inc. (Nasdaq: NCNO), a cloud-based software company specializing in banking solutions, announced first-quarter fiscal 2024 earnings per share (EPS) of $0.07, surpassing market consensus estimates of $0.05. 

The company also provided guidance for the second quarter of fiscal 2024, expecting non-GAAP net income per share in the range of $0.06 to $0.08, slightly deviating from the consensus estimate of $0.08. 

Following the earnings release, $NCNO experienced a decline of $3.42 (-12.44%) in after-hours, trading at $24.07.

Additionally, PVH Corp. (NYSE: PVH), a diversified global apparel company that owns popular brands such as Calvin Klein and Tommy Hilfiger, reported first-quarter 2023 earnings per share (EPS) of $2.14, surpassing the consensus estimate of $1.93. 

For the second quarter of 2023, PVH expects non-GAAP EPS of $2.08, slightly lower than the consensus estimate of $2.26. 

$PVH experienced a decrease of $1.27 (-1.48%) in after-hours, trading at $84.75. 

Investors should carefully consider these updates and conduct their own analysis before making any investment decisions. After-hours trading prices can be volatile and may not reflect the market's opening prices

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)